Interventional Cardiology: Implantable Cardioverter Defibrillators | Global Markets

63 Pages | 25 Exhibits | 2019 Analysis | Forecasts Through 2023
Buy Now
Become Market Insider

Overview

This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global ICD products market, including standard ICDs, subcutaneous ICDs, and cardiac resynchronization therapy-defibrillator (CRT-D) systems.

ICD MARKET HIGHLIGHTS

  • The most influential driver of the global ICDs market is the increasing prevalence of cardiovascular disease as a result of the expanding geriatric population and an increasing prevalence of CVD risk factors such as obesity and diabetes.
  • The combined global market for ICD devices totals nearly $8bn, and is expected to climb at a CAGR of 4.4% through 2023.
  • The US and five major EU markets each accounted for more than one-third of global ICD sales in 2018, with the RoWsegment accounting for nearly one-quarter of sales and Japan accounting for 6%.
  • Current technological trends in the global ICDs market include remote monitoring applications, new algorithms for the discrimination of significant arrhythmias, software to improve battery life, MRI compatibility, and quadripolar leads.

 

KEY QUESTIONS ANSWERED

  • What are the key drivers and limiters to the global ICD products market?
  • Which competitors are leading the market and introducing new technology?
  • How are technological advancements impacting market growth?
  • Which areas of the ICD products market are experiencing dynamic growth?
  • How are mergers and acquisitions affecting the markets shares of leading competitors?

Table of Contents

Executive Summary

i. Cardiac rhythm disorders overview

ii. Global implantable cardioverter defibrillator products market 

a. Market drivers and limiters

b. Device segment insights 

c. Technology trends

d. Market leaders

e. Competitive strategies

f. Emerging competition 

iii. Methodology

 

Exhibit ES-1: Global implantable cardioverter defibrillator products market forecast ($m), 2018-23

Exhibit ES-2: Global implantable cardioverter defibrillator products market, by country/region, 2018 

Exhibit ES-3: Drivers and limiters of growth - implantable cardioverter defibrillator products

 

1. Cardiac Rhythm Disorders Overview

1.1 Sick sinus syndrome

1.2 Bradycardia 

1.3 Heart block

1.4 Tachycardia 

1.5 Atrial fibrillation

1.6 Heart failure

1.7 Diagnosis and treatment

1.8 Bibliography 

 

Exhibit 1-1: Estimated prevalence rates of conduction disorders and cardiac arrhythmias, based on healthcare utilization, select countries

Exhibit 1-2: Estimated number of hospital discharges for conduction disorders and cardiac arrhythmias, select countries

Exhibit 1-3: Estimated prevalence of atrial fibrillation, select countries, 2018

Exhibit 1-4: Estimated prevalence of chronic heart failure, select countries, 2018

Exhibit 1-5: Estimated prevalence of acute decompensated heart failure, select countries, 2018

 

2. Implantable Cardioverter Defibrillator Products 

2.1 Implantable cardioverter defibrillator systems

2.1.1 Implantable cardioverter defibrillator products

2.1.2 Developments in implantable cardioverter defibrillator technology

2.2 Bibliography 

 

Exhibit 2-1: Generic NBD codes for implantable cardioverter defibrillators

Exhibit 2-2: Selected ICDs and manufacturers

Exhibit 2-3: Selected CRT-Ds and manufacturers 

 

3. Implantable Cardioverter Defibrillator Products Market

3.1 Global market insights

3.1.1 Market value

3.1.2 Technology trends 

3.1.3 Market drivers and limiters 

3.1.4 ICD products overview

3.1.5 Market leaders

3.1.6 Competitive strategies

3.1.7 Emerging competition 

3.2 Global competitors 

3.3 Market forecast

3.3.1 Market forecast: US 

3.3.2 Market forecast: five major EU markets

3.3.3 Market forecast: Japan 

3.3.4 Market forecast: rest of the world 

3.4 Bibliography 

 

Exhibit 3-1: ICD products, global market forecast ($m), 2018-23 

Exhibit 3-2: ICD products, global market forecast ($m), by product type, 2018-23

Exhibit 3-3: Global ICD products market, share by country/region, 2018

Exhibit 3-4: Global ICD product sales, global market forecast ($m), by country/region, 2018-23

Exhibit 3-5: Drivers and limiters of market growth – ICD products

Exhibit 3-6: ICD products, global market forecast ($m), by product type, 2018-23

Exhibit 3-7: Global ICD products market, share by supplier, 2018

Exhibit 3-8: US ICD implantations, procedure volumes forecast (000s), 2018-23

Exhibit 3-9: US ICD product sales, market forecast ($m), by product type, 2018-23

Exhibit 3-10: 5EU ICD implantations, procedure volumes forecast (000s), 2018-23

Exhibit 3-11: 5EU ICD product sales, market forecast ($m), by product type, 2018-23

Exhibit 3-12: Japanese ICD implantations, procedure volumes forecast (000s), 2018-23 

Exhibit 3-13: Japanese ICD product sales, market forecast ($m), by product type, 2018-23

Exhibit 3-14: RoW ICD product sales, market forecast ($m), by product type, 2018-23 

 

Appendix: Company Listing

Companies Covered

Abbott

BIOTRONIK

Boston Children's Hospital

Boston Scientific

Harvard University

Medtronic

MicroPort Scientific